1 MONTELUKAST SODIUM | 110 of 1960 | 3250 prescriptions Less than 1% of all prescriptions | 2290 | 840 patients 24% of all patients | 570 patients 16% of all patients | |
2 BREO ELLIPTA (FLUTICASONE/VILANTEROL) | 270 of 1800 | 1480 prescriptions Less than 1% of all prescriptions | 1270 | 430 patients 12% of all patients | < 11 | |
3 ANORO ELLIPTA (UMECLIDINIUM BRM/VILANTEROL TR) | 130 of 1590 | 1680 prescriptions Less than 1% of all prescriptions | 1250 | 480 patients 14% of all patients | 330 patients 9% of all patients | |
4 SYMBICORT (BUDESONIDE/FORMOTEROL FUMARATE) | 320 of 1950 | 1160 prescriptions Less than 1% of all prescriptions | 900 | 330 patients 9% of all patients | < 11 | |
5 VENTOLIN HFA (ALBUTEROL SULFATE) | 290 of 2080 | 1490 prescriptions Less than 1% of all prescriptions | 940 | 690 patients 20% of all patients | 430 patients 12% of all patients | |
6 PROAIR HFA (ALBUTEROL SULFATE) | 110 of 1860 | 1360 prescriptions Less than 1% of all prescriptions | 820 | 600 patients 17% of all patients | 430 patients 12% of all patients | |
7 ZOLPIDEM TARTRATE | 10 of 340 | 860 prescriptions Less than 1% of all prescriptions | 320 | 190 patients 5% of all patients | < 11 | |
8 ADVAIR DISKUS (FLUTICASONE PROPION/SALMETEROL) | 560 of 1980 | 620 prescriptions Less than 1% of all prescriptions | 280 | 220 patients 6% of all patients | 110 patients 3% of all patients | |
9 SPIRIVA (TIOTROPIUM BROMIDE) | 730 of 1790 | 360 prescriptions Less than 1% of all prescriptions | 220 | 130 patients 4% of all patients | < 11 | |
10 TRELEGY ELLIPTA (FLUTICASONE/UMECLIDIN/VILANTER) | 80 of 710 | 530 prescriptions Less than 1% of all prescriptions | 360 | 210 patients 6% of all patients | < 11 | |
11 TRIAMTERENE-HYDROCHLOROTHIAZID (TRIAMTERENE/HYDROCHLOROTHIAZID) | 30 of 70 | 350 prescriptions Less than 1% of all prescriptions | 230 | 140 patients 4% of all patients | < 11 | |
12 PREDNISONE | 790 of 2010 | 680 prescriptions Less than 1% of all prescriptions | 370 | 330 patients 9% of all patients | 220 patients 6% of all patients | |
13 ELIQUIS (APIXABAN) | 70 of 270 | 290 prescriptions Less than 1% of all prescriptions | 290 | < 11 | < 11 | |
14 SPIRIVA RESPIMAT (TIOTROPIUM BROMIDE) | 710 of 1560 | 250 prescriptions Less than 1% of all prescriptions | | < 11 | < 11 | |
15 FLUTICASONE PROPIONATE | 350 of 1450 | 380 prescriptions Less than 1% of all prescriptions | 250 | 130 patients 4% of all patients | < 11 | |
16 ARNUITY ELLIPTA (FLUTICASONE FUROATE) | 90 of 560 | 400 prescriptions Less than 1% of all prescriptions | 250 | < 11 | < 11 | |
17 INCRUSE ELLIPTA (UMECLIDINIUM BROMIDE) | 670 of 1540 | 200 prescriptions Less than 1% of all prescriptions | | < 11 | < 11 | |
18 STIOLTO RESPIMAT (TIOTROPIUM BR/OLODATEROL HCL) | 400 of 1000 | 240 prescriptions Less than 1% of all prescriptions | 130 | < 11 | < 11 | |
19 XARELTO (RIVAROXABAN) | 100 of 310 | 160 prescriptions Less than 1% of all prescriptions | | < 11 | < 11 | |
20 MOMETASONE FUROATE | 90 of 110 | 120 prescriptions Less than 1% of all prescriptions | 00 | < 11 | 00 patients Less than 1% of all patients | |
21 PANTOPRAZOLE SODIUM | 220 of 550 | 130 prescriptions Less than 1% of all prescriptions | | < 11 | < 11 | |
22 TRAZODONE HCL | 160 of 180 | 110 prescriptions Less than 1% of all prescriptions | | < 11 | < 11 | |
23 ALPRAZOLAM | 100 of 330 | 190 prescriptions Less than 1% of all prescriptions | | < 11 | < 11 | |
24 CLONAZEPAM | 170 of 300 | 130 prescriptions Less than 1% of all prescriptions | 00 | < 11 | 00 patients Less than 1% of all patients | |
25 FLOVENT HFA (FLUTICASONE PROPIONATE) | 310 of 740 | 120 prescriptions Less than 1% of all prescriptions | | < 11 | < 11 | |
26 THEOPHYLLINE (THEOPHYLLINE ANHYDROUS) | 190 of 250 | 120 prescriptions Less than 1% of all prescriptions | 00 | < 11 | 00 patients Less than 1% of all patients | |
27 DIAZEPAM | 10 of 40 | 240 prescriptions Less than 1% of all prescriptions | 00 | < 11 | 00 patients Less than 1% of all patients | |
28 METHYLPREDNISOLONE | 60 of 220 | 280 prescriptions Less than 1% of all prescriptions | 170 | 260 patients 7% of all patients | 150 patients 4% of all patients | |
29 CEFUROXIME (CEFUROXIME AXETIL) | 80 of 220 | 190 prescriptions Less than 1% of all prescriptions | | 190 patients 5% of all patients | < 11 | A |